To this end, 1 week after intrahepatic administration of either Lv.TβRII-SE/Fc or control Lv.TβRII-Fc, liver fibrosis was induced by chronic administration of the hepatotoxic agent CCl4 for 8 weeks (Figure 5A). The gene discussed is TGFBR2; the disease is Hepatic fibrosis.